Advertisement
Screener

GREENWICH LIFESCIENCES, INC. (GLSI) Proceeds from Issuance of Private Placement

2.4 / 5 stars · 16/33 Roast Me

GREENWICH LIFESCIENCES, INC. Proceeds from Issuance of Private Placement

GREENWICH LIFESCIENCES, INC. (GLSI) reported Proceeds from Issuance of Private Placement of $2.50 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-06-01.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2026-06-01

  • GREENWICH LIFESCIENCES, INC. proceeds from issuance of private placement for the quarter ending 2024-12-31 was $0.00.
  • GREENWICH LIFESCIENCES, INC. proceeds from issuance of private placement for the quarter ending 2024-09-30 was $0.00.
  • GREENWICH LIFESCIENCES, INC. proceeds from issuance of private placement for fiscal 2024 was $2.50M.
Period endProceeds from Issuance of Private Placement 3 monthProceeds from Issuance of Private Placement 6 monthProceeds from Issuance of Private Placement 9 monthProceeds from Issuance of Private Placement 12 month
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01
$0.00
derived: sum of 2 quarters · filed 2026-06-01
$2.50M
10-K · filed 2026-06-01
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
$2.50M
10-Q · filed 2025-11-14
2024-06-30$2.50M
10-Q · filed 2025-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Mereo BioPharma Group plc (MREO)$0.269B-9.41
Akebia Therapeutics, Inc. (AKBA)United States$0.255B-10.35
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73